Loading…
HeartBeam, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▼ -89.9% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 5 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $2.40 | $2.30 | $2.35 | $4.88 | $3.08 | |
| P/B | 16.9x | 37.9x | 46.9x | 3.9x | 16.9x | 1.8x |
| EPS | -$0.62 | -$0.73 | -$0.72 | -$1.59 | -$1.03 | |
| ROE | -546.00% | -807.34% | -1175.82% | -91.86% | -546.00% | -33.02% |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| LTRNLantern Pharma Inc. | $2.07 | — | — | — | -400.92% | $26.46M |
| FEMYFemasys Inc | $3.20 | — | 2.4x | — | -424.97% | $26.8M |
| ATOSAtossa Therapeutics Inc | $2.58 | — | 1.0x | — | -89.23% | $25.75M |
| ARAYAccuray Inc | $0.23 |
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
Company description provided by Yahoo Finance.
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 0.6x |
| — |
| -80.08% |
| $26.93M |
| BYSIBeyondSpring Inc. | $0.67 | — | — | — | — | $27.36M |
| PLRZPolyrizon Ltd. | $13.15 | — | 1.0x | — | -25.38% | $27.39M |